unedited summary of todays excellent poh ann , page-2

$10.9m in the bank @31/12 and net cash burn of $9m over the year. Launch of the cosmeceutical range will increase cash burn at least initially tho' the company see it as a cash generator. Assuming it breaks even or makes some contribution over the year, POH has about a year's cash left.

It points up how vital the Oxycodone results have been. The Company needs quick licencing monies. Without the apparently excellent results, would that have been easy?
The management's apparent euphoria on their announcement not, perhaps, surprising!

The tide must now be running for POH. It will a comfort, nonetheless, to have an agreement(s) signed & sealed by mid year before things begin to look tight.